Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1BAYN - DE000BAY0017 - Common Stock

30.705 EUR
+0.08 (+0.26%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 55 industry peers in the Pharmaceuticals industry. 1BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

1BAYN has a worse Return On Assets (-0.19%) than 63.64% of its industry peers.
1BAYN's Return On Equity of -0.67% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 63.64% of its industry peers.
With a Return On Invested Capital value of 1.92%, 1BAYN is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
1BAYN had an Average Return On Invested Capital over the past 3 years of 5.87%. This is significantly below the industry average of 13.92%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.92%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

1BAYN's Operating Margin of 4.20% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 65.45% of its industry peers.
In the last couple of years the Operating Margin of 1BAYN has declined.
Looking at the Gross Margin, with a value of 56.35%, 1BAYN is doing worse than 70.91% of the companies in the same industry.
1BAYN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1BAYN is destroying value.
The number of shares outstanding for 1BAYN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1BAYN has about the same amount of shares outstanding.
1BAYN has a better debt/assets ratio than last year.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1BAYN has an Altman-Z score of 0.91. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
1BAYN has a Altman-Z score of 0.91. This is in the lower half of the industry: 1BAYN underperforms 72.73% of its industry peers.
The Debt to FCF ratio of 1BAYN is 10.07, which is on the high side as it means it would take 1BAYN, 10.07 years of fcf income to pay off all of its debts.
1BAYN has a worse Debt to FCF ratio (10.07) than 67.27% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 65.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 0.91
ROIC/WACC0.29
WACC6.71%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.14 indicates that 1BAYN should not have too much problems paying its short term obligations.
1BAYN has a Current ratio of 1.14. This is in the lower half of the industry: 1BAYN underperforms 69.09% of its industry peers.
A Quick Ratio of 0.71 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN has a worse Quick ratio (0.71) than 76.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

3

3. Growth

3.1 Past

The earnings per share for 1BAYN have decreased by -8.72% in the last year.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -1.87%.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%

3.2 Future

1BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.44% yearly.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.75 indicates a rather cheap valuation of 1BAYN.
96.36% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, 1BAYN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.30, the valuation of 1BAYN can be described as very cheap.
1BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 94.55% of the companies in the same industry.
1BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.56.
Industry RankSector Rank
PE 5.75
Fwd PE 6.3
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAYN indicates a somewhat cheap valuation: 1BAYN is cheaper than 69.09% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.67
EV/EBITDA 9.96
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%

0

5. Dividend

5.1 Amount

1BAYN has a yearly dividend return of 0.36%, which is pretty low.
Compared to an average industry Dividend Yield of 2.86, 1BAYN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.32, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

BAYER AG-REG

BIT:1BAYN (11/28/2025, 7:00:00 PM)

30.705

+0.08 (+0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.17B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price Target29.59 (-3.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)2.27%
PT rev (3m)1.76%
EPS NQ rev (1m)-16.13%
EPS NQ rev (3m)-16.44%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 5.75
Fwd PE 6.3
P/S 0.66
P/FCF 7.67
P/OCF 4.49
P/B 1.02
P/tB N/A
EV/EBITDA 9.96
EPS(TTM)5.34
EY17.39%
EPS(NY)4.87
Fwd EY15.87%
FCF(TTM)4.01
FCFY13.04%
OCF(TTM)6.84
OCFY22.29%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.92%
ROICexc 2.13%
ROICexgc 7.24%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
ROICexc(3y)6.62%
ROICexc(5y)N/A
ROICexgc(3y)27.47%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 0.91
F-Score5
WACC6.71%
ROIC/WACC0.29
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / 1BAYN.MI FAQ

What is the fundamental rating for 1BAYN stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.


What is the valuation status for 1BAYN stock?

ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.


Can you provide the profitability details for BAYER AG-REG?

BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for BAYER AG-REG?

The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -6.5% in the next year.


Is the dividend of BAYER AG-REG sustainable?

The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -65.15%.